全髋关节置换术后心肌钴水平升高
该研究查询本机构1990至2013年间接受全髋关节置换术(THA)者的尸检档案,采用电感耦合等离子体质谱法检测心肌组织钴(Co)和铬(Cr)水平。纳入75例Co/Cr-聚乙烯THA病例和73例按年龄、性别及高血压和糖尿病史匹配的非关节置换对照。THA组心肌钴中位浓度显著高于对照组(0.12 vs 0.06 μg/g,p < 0.0001),翻修THA患者钴中位浓度较初次THA高69%(0.169 vs 0.100 μg/g,p = 0.004);植入物患者尸检样本中心脏肥大、间质纤维化和射血分数降低更常见。
要点
- THA患者心肌钴中位浓度显著高于对照(0.12 vs 0.06 μg/g,p < 0.0001)。
- 翻修THA患者心肌钴中位浓度较初次THA高69%(0.169 vs 0.100 μg/g,p = 0.004)。
- 植入物患者心脏肥大、间质纤维化和射血分数降低更常见(p分别为0.0002、0.044、0.0039)。
核心结论
- 作者认为这是首项量化关节置换与非置换患者心肌金属水平的研究;关节置换队列中钴水平升高并伴尸检发现的心脏肥大和间质纤维化增加是新发现。
- 尽管钴水平显著高于对照,但多数低于金属对金属假体相关钴心脏毒性死亡临床病例报告中所见的水平。
研究设计与样本
- 查询本机构1990至2013年间接受THA者的尸检档案,采用电感耦合等离子体质谱法分析心肌组织钴和铬水平。
- 纳入75例Co/Cr-聚乙烯THA病例(死亡时平均年龄77.4岁,女性49%)和73例按年龄、性别及高血压和糖尿病史匹配的非关节置换对照。
主要发现
- THA患者心肌钴中位浓度显著高于对照(0.12 vs 0.06 μg/g,p < 0.0001)。
- 翻修THA患者心肌钴中位浓度较初次THA高69%(0.169 vs 0.100 μg/g,p = 0.004)。
- 多关节置换者钴水平总体更高,但该发现仅趋势 toward 显著性。
- 植入物患者尸检样本中心脏肥大、间质纤维化和射血分数降低较对照更常见(p分别为0.0002、0.044、0.0039)。
局限性
- 多关节置换者钴水平更高的发现仅趋势 toward 显著性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Arthroplasty implants commonly contain elemental metal that may undergo wear-related release. Recently, cases of hip implant-associated myocardial injury have been reported. However, we are not aware of any previous study that has systematically measured myocardial metal levels or examined the relationship with total hip arthroplasty (THA). METHODS: Archives of our institution were queried for autopsies of individuals who had undergone THA between 1990 and 2013. Myocardial tissue samples were analyzed for cobalt (Co) and chromium (Cr) levels with inductively coupled plasma mass spectroscopy. Seventy-five Co/Cr-on-polyethylene THA cases were included (mean age at time of death = 77.4 years; 49% women) as were 73 non-arthroplasty controls matched for age, sex, and history of hypertension and diabetes mellitus. RESULTS: Significantly higher median myocardial concentrations of Co were observed in individuals with THA compared with controls (0.12 versus 0.06 μg/g, p < 0.0001). The median Co concentration was 69% higher in patients who had undergone THA revision (0.169 μg/g) than in those who underwent primary THA (0.100 μg/g; p = 0.004). In general, higher Co levels were observed in those with multiple replaced joints, although this finding only trended toward significance. Cardiomegaly, interstitial fibrosis, and decreased ejection fraction were observed more frequently in the postmortem samples of patients with implants than in those of controls (p = 0.0002, 0.044, and 0.0039, respectively). CONCLUSIONS: We believe this to be the first study to quantify metal levels in cardiac tissue in patients with and without joint replacement. The elevated Co levels, in concert with cardiomegaly and increased interstitial fibrosis found during autopsy, in the arthroplasty cohort are novel, important findings. Although Co levels were significantly elevated above those in controls, the majority were below those seen in clinical case reports of death from Co cardiotoxicity associated with metal-on-metal prostheses. LEVEL OF EVIDENCE: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.
引用
- Wyles CC, Wright TC, Bois MC, et al. Myocardial Cobalt Levels Are Elevated in the Setting of Total Hip Arthroplasty. J Bone Joint Surg Am. 2017. PMID: 29135673. doi:10.2106/JBJS.17.00159
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。